Literature DB >> 1725301

Production of endothelin by vascular smooth muscle cells.

S M Kanse1, K Takahashi, J B Warren, T Perera, M Porta, M Ghatei, S R Bloom.   

Abstract

Endothelin (ET) production by cultured vascular smooth muscle cells isolated from rat and rabbit aortae was measured by a specific radioimmunoassay. Vascular smooth muscle cells released ET at a rate of 0.6 (range of 0.1-1) fmol/10(5) cells/24 h compared to 45 (range of 10-80) fmol/10(5) cells/h for endothelial cells. ET immunoreactivity was confirmed as ET-1 by fast protein liquid chromatography. Calcitonin gene-related peptide (CGRP) and vasoactive intestinal polypeptide (VIP) suppressed basal release of ET by 24-66% from both rat and rabbit vascular smooth muscle. Forskolin and dibutryl-cAMP similarly suppressed ET release by 33-86%, suggesting that increased intracellular cAMP may account for the mechanism of action of CGRP and VIP. In contrast, CGRP and VIP did not have any effect on ET release from endothelial cells. The characteristics and regulation of ET binding sites on vascular smooth muscle cells were measured using [125I]ET-1 as the radioligand. Pretreatment with CGRP, VIP, forskolin, and dibutryl-cAMP increased the ET receptor density on both smooth muscle cell types. The low level production of ET-1 by vascular smooth muscle cells may have an important autocrine function and may be under regulation of neuropeptides localized to perivascular nerves.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1725301     DOI: 10.1097/00005344-199100177-00029

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  8 in total

1.  Potential role of endothelin receptor antagonists in the setting of cardiopulmonary bypass: relevance to myocardial performance.

Authors:  A Ergul; C Joffs; A C Walker; F G Spinale
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

2.  [Pathomorphology of coronary atherosclerosis].

Authors:  C Ihling
Journal:  Herz       Date:  1998-03       Impact factor: 1.443

Review 3.  ET-1 as a Sex-Specific Mechanism Impacting Age-Related Changes in Vascular Function.

Authors:  Andrew V Kuczmarski; Laura M Welti; Kerrie L Moreau; Megan M Wenner
Journal:  Front Aging       Date:  2021-08-31

Review 4.  Vasotrophic regulation of age-dependent hypoxic cerebrovascular remodeling.

Authors:  Jinjutha Silpanisong; William J Pearce
Journal:  Curr Vasc Pharmacol       Date:  2013-09       Impact factor: 2.719

5.  A study of the effects of human blood derivatives and individual growth factors on [3H]thymidine uptake in bovine retinal pericytes and endothelial cells.

Authors:  A A Dosso; R A Brooks; E Beltramo; P A Molinatti; S M Kanse; E M Kohner; M Porta
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

6.  Involvement of the metabolic sensor GPR81 in cardiovascular control.

Authors:  Kristina Wallenius; Pia Thalén; Jan-Arne Björkman; Petra Johannesson; John Wiseman; Gerhard Böttcher; Ola Fjellström; Nicholas D Oakes
Journal:  JCI Insight       Date:  2017-10-05

7.  Glucocorticoids regulate the expression of the human osteoblastic endothelin A receptor gene.

Authors:  I Börcsök; H U Schairer; U Sommer; G K Wakley; U Schneider; F Geiger; F U Niethard; R Ziegler; C H Kasperk
Journal:  J Exp Med       Date:  1998-11-02       Impact factor: 14.307

8.  Endothelin-1 Mediates the Systemic and Renal Hemodynamic Effects of GPR81 Activation.

Authors:  Natalie K Jones; Kevin Stewart; Alicja Czopek; Robert I Menzies; Adrian Thomson; Carmel M Moran; Carolynn Cairns; Bryan R Conway; Laura Denby; Dawn E W Livingstone; John Wiseman; Patrick W Hadoke; David J Webb; Neeraj Dhaun; James W Dear; John J Mullins; Matthew A Bailey
Journal:  Hypertension       Date:  2020-03-23       Impact factor: 10.190

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.